Impact of Weight Loss After a Bypass Surgery on Renal Hemodynamic Under Stress Conditions
NCT02218112 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2018-03-16
Summary
The sympathetic nervous (SNS) and the renin angiotensin aldosterone system (RAS) have a direct impact on renal hemodynamic, hormonal secretion and vasoactive peptide. Many mechanisms including the SNS, RAS and renal sodium handling could explain the pathogenesis of hypertension in obese patients. Lifestyle changes and bariatric surgery induce weight loss, which is associated with blood pressure lowering in obese patients. A diminution in the renal sympathetic stimulation and RAS activation could explain this effect.
The AIM of this study is to show that weight loss induced by bypass surgery in obese patients affects renal salt excretion under " low body negative pressure (LBNP)" conditions .
Secondary objectives are to investigate the impact of weight loss on renal hemodynamic (glomerular filtration rate (GFR), renal plasma flow) and neurohormonal responses under " low body negative pressure conditions ". We will also analyse renal blood oxygenation with Blood Oxygenation dependant IRM (BOLD-IRM) technique before and after weight loss.
The population of this study will consist in two groups including 36 patients. The first one will include 24 obese patients that are going to undergo a bariatric surgery. The second one will include 12 obese patients without any weight loss associated surgery.
Both group will undergo 3 investigation days. Each patient will have to undergo a screening visit that will provide dietary advice to ensure a standardized salt intake (120-180 mmol/day) for the duration of the study. The first investigation will define baseline, the second and third day of investigation will take place after 3 month and 12 month after bariatric surgery for surgical patients or after baseline for patients without surgery. One to two weeks before phase 1 and 3 patients will perform a BOLD-MRI. The surgery group will undergo bariatric surgery between the first investigation phase (baseline) and the second. An ambulatory blood pressure and 24-hour urine collection will precede each investigation day. An investigation day consists in renal hemodynamics, neurohormonal and natriuretic response measurements before, during and after 60 min of LBNP at -30mbar . The duration of the study per subject is going to take 12 months.
Conditions
- Obesity
- Bariatric Surgery
- Blood Pressure
Interventions
- PROCEDURE
-
bariatric surgery (gastric bypass)
Sponsors & Collaborators
-
Centre Hospitalier Universitaire Vaudois
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2017-07-31
- Completion
- 2017-07-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery
NCT06278285 ·Status: RECRUITING ·Phase: NA
-
Weight Loss in Obese Kidney Disease Patients After Bariatric Surgery
NCT02644928 ·Status: COMPLETED
-
Blood Pressure Changes After Bariatric Surgery
NCT06460233 ·Status: COMPLETED
-
Nutritional Status of prEgnant Women Following BariatrIc surgEry
NCT06796829 ·Status: COMPLETED
-
The Effect of Bariatric Surgery on Thyroid Function and Morphology
NCT00871130 ·Status: COMPLETED
-
Endocrinological and Neuronal Aspects of Bariatric Surgery
NCT04634929 ·Status: UNKNOWN
-
Kidney Function Indexed Extracellular Volume Before and After Obesity Surgery
NCT02830646 ·Status: UNKNOWN ·Phase: NA
-
Nephrolithiasis and Bariatric Surgery
NCT00169793 ·Status: COMPLETED ·Phase: NA
-
Effects of Bariatric Surgery on Cardiovascular Risk Profile in Relation to Inflammatory Parameters: Endothelial Phenotyping and Analysis of the Cross-talk Between Adipose Tissue and Endothelium
NCT07131605 ·Status: RECRUITING ·Phase: NA
-
Diastolic Dysfunction in Morbidly Obese Patients Undergo Bariatric Surgery
NCT04128735 ·Status: COMPLETED
-
Evaluation of Characteristics of Patients With Nonsurgical Complications After Bariatric Surgery and Quality of Life
NCT05957237 ·Status: COMPLETED
-
The Effect of Intrabdominal Pressure in Patients Undergoing Bariatric Surgery
NCT04929639 ·Status: COMPLETED
-
Bariatric Surgery and the Kidney
NCT01410994 ·Status: COMPLETED
-
Gastro-Intestinal Digestion and Physiology After Bariatric Surgery
NCT07286968 ·Status: RECRUITING
-
Evaluation of Cortisol and Bile Acids Metabolism in Obese Patients
NCT04844684 ·Status: RECRUITING
-
The Effect of Bariatric/Metabolic Surgery on GFR
NCT02406664 ·Status: UNKNOWN ·Phase: NA
-
Reversal of Obese/Diabetic Cardiomyopathy After Gastric Bypass Surgery
NCT01067209 ·Status: COMPLETED
-
Gut Hormones as Mediators of Different Weight Loss Responses After Roux-en-Y Gastric Bypass
NCT02374632 ·Status: UNKNOWN ·Phase: PHASE4
-
Changes in Body Fat and Morphologic Characteristics Associated With OSA Resolution After Bariatric Surgery
NCT05315752 ·Status: RECRUITING
-
Influence of Bariatric Surgery on Serum Levels of 26RFa
NCT01982019 ·Status: COMPLETED ·Phase: NA
-
Effects of Roux-en-Y Gastric Bypass on Gastro-intestinal Hormone Secretion and Brain Responses Food Pictures
NCT02160379 ·Status: COMPLETED
-
Impact of Bariatric Surgery on Pharmacokinetic Study of Simvastatin and Carvedilol
NCT04049786 ·Status: UNKNOWN ·Phase: PHASE4
-
Influence of Obesity and Gastric Bypass on Medication Absorption
NCT01571180 ·Status: UNKNOWN
-
Prospective Study of Hormone Levels After Bariatric Surgery
NCT00627315 ·Status: COMPLETED
-
Prospective Cohort Study of the Effect of Bariatric/Metabolic Surgery on Morbid Obesity Patients With Metabolic Syndrome
NCT02271568 ·Status: UNKNOWN